|
CN107998150A
|
|
Comprise mean for the composition that implantation suppresses tumour growth and prevents the sarcoblast of cancer metastasis
|
|
EP3298978A1
|
|
Autonomously controllable pull wire injection catheter and a robotic system comprising said catheter
|
|
US2015050300A1
|
|
Disease prevention and alleviation by human myoblast transplantation
|
|
AU2007202290A1
|
|
Myogenic cell transfer catheter and method
|
|
WO2005020916A2
|
|
Myoblast treatment of diseased or weakened organs
|
|
WO2004030706A2
|
|
Bioactive implants
|
|
WO2004017972A1
|
|
Biologic skin repair and enhancement
|
|
CA2495112A1
|
|
Mechanisms of myoblast transfer in treating heart failure
|
|
EP1497410A2
|
|
Cellular transplantation for heart regeneration
|
|
AU1123002A
|
|
Myogenic cell transfer catheter and method
|
|
AU5831199A
|
|
Myoblast therapy for mammalian diseases
|
|
CA2225185A1
|
|
Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
|
|
EP1407788A2
|
|
Myoblast therapy for mammalian diseases
|
|
US5130141A
|
|
Compositions for and methods of treating muscle degeneration and weakness
|
